Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotic Medications

NCT00458211 is registered in ClinicalTrials.gov with Bronx Psychiatric Center as lead sponsor.

NCT NCT00458211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00458211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotic Medications
Lead sponsor
Bronx Psychiatric Center
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2005
Completion date
April 30, 2008
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia